Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Anthem beats earnings estimates, raises 2019 profit forecast

Published 04/24/2019, 07:32 AM
Updated 04/24/2019, 07:35 AM
© Reuters. FILE PHOTO: The logo for health insurance provider, Anthem, is displayed on a screen on the floor at the NYSE in New York

(Reuters) - Anthem (NYSE:ANTM) Inc's first-quarter profit beat Wall Street estimates on Wednesday as it reined in expenses, and the U.S. health insurer raised its earnings forecast for the year.

Shares of the Indiana-based company rose 2.7 percent to $257.39 before the opening bell.

Last year, the health insurance sector experienced its biggest shake up in years, as rivals Aetna (NYSE:AET) and Cigna Corp (NYSE:CI) closed deals with the biggest U.S. pharmacy benefits managers.

Anthem, which operates Blue Cross Blue Shield plans in 14 states, also overhauled its pharmacy benefits business after years of relying on Express Scripts (NASDAQ:ESRX) to handle those operations. Its new company, IngenioRx, is expected to be launched during the second quarter with the help of CVS Health Corp (NYSE:CVS).

For 2019, Anthem said it expects adjusted earnings to be above $19.20 per share, higher than its prior estimate of more than $19.00.

Members in the company's health plans rose by 1.2 million to 40.8 million, helped by growth in the government business that provides Medicare health plans for people aged 65 and older and Medicaid plans for the poor.

The company gained market share across its commercial, Medicare and Medicaid businesses and its earnings forecast for the year beat the average Wall Street estimate of $19.17, implying consensus estimates will move higher, Stephens Inc analyst Scott Fidel said.

Anthem's benefit expense ratio — the percentage of premiums taken in that are paid out for medical services — worsened to 84.4 percent in the quarter from 81.5 percent a year earlier, partly due to a one-year waiver of the health insurance tax in 2019. Analysts on average had expected 84 percent, according to IBES data from Refinitiv.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company said certain states in which it runs Medicaid plans saw higher medical costs.

Net income rose 18.2 percent to $1.55 billion, or $5.91 per share, in the quarter ended March 31.

Excluding items, the company earned $6.03 per share, ahead of the average analyst estimate of $5.81.

Total revenue rose 9.4 percent to $24.67 billion, beating analysts' estimates of $24.28 billion, helped by membership growth across the company's businesses and premium rate increases.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.